To download the invitation please click on the link below:
Malaria kills about 500 000 people each year in Africa and about half of them are children. In 2019 alone there was 229 million malaria related cases and 409 000 deaths. Sub Saharan Africa,bconstituted 94% of the reported cases and deaths with 67% of the overall morbidity and mortalityboccurring in children under the age of 5 years. Prevention and treatment measures in place haveb been responsible for reducing the disease burden.
These includes vector control, and prophylacticvdrugs for prevention, and Artemisinin-based Combination Therapy (ACT) for treatment. However, antimalarial drug resistance has been a recurring problem since the early 950s. This has led to further research culminating in the development of vaccines. Vaccination against human parasites has been a challenge for researchers. Until recently, there was no effective vaccine available. ThebGSK vaccine is the rst to show fair efcacy in reducing malaria fatalities and life threatening severe malaria in children.
Through this dialogue, the intention is to invest in scholarly inquiry and contribute creatively to the research conversation.